Literature DB >> 26212325

Metabolic Interplay between Astrocytes and Neurons Regulates Endocannabinoid Action.

Andreu Viader1, Jacqueline L Blankman2, Peng Zhong3, Xiaojie Liu3, Joel E Schlosburg4, Christopher M Joslyn1, Qing-Song Liu3, Aaron J Tomarchio5, Aron H Lichtman5, Dana E Selley5, Laura J Sim-Selley5, Benjamin F Cravatt6.   

Abstract

The endocannabinoid 2-arachidonoylglycerol (2-AG) is a retrograde lipid messenger that modulates synaptic function, neurophysiology, and behavior. 2-AG signaling is terminated by enzymatic hydrolysis-a reaction that is principally performed by monoacylglycerol lipase (MAGL). MAGL is broadly expressed throughout the nervous system, and the contributions of different brain cell types to the regulation of 2-AG activity in vivo remain poorly understood. Here, we genetically dissect the cellular anatomy of MAGL-mediated 2-AG metabolism in the brain and show that neurons and astrocytes coordinately regulate 2-AG content and endocannabinoid-dependent forms of synaptic plasticity and behavior. We also find that astrocytic MAGL is mainly responsible for converting 2-AG to neuroinflammatory prostaglandins via a mechanism that may involve transcellular shuttling of lipid substrates. Astrocytic-neuronal interplay thus provides distributed oversight of 2-AG metabolism and function and, through doing so, protects the nervous system from excessive CB1 receptor activation and promotes endocannabinoid crosstalk with other lipid transmitter systems.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26212325      PMCID: PMC4526356          DOI: 10.1016/j.celrep.2015.06.075

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  53 in total

Review 1.  A historical overview of chemical research on cannabinoids.

Authors:  R Mechoulam; L Hanus
Journal:  Chem Phys Lipids       Date:  2000-11       Impact factor: 3.329

2.  Transgenic techniques for cell ablation or molecular deletion to investigate functions of astrocytes and other GFAP-expressing cell types.

Authors:  Michael V Sofroniew
Journal:  Methods Mol Biol       Date:  2012

Review 3.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

4.  Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice.

Authors:  Bin Pan; Wei Wang; Peng Zhong; Jacqueline L Blankman; Benjamin F Cravatt; Qing-song Liu
Journal:  J Neurosci       Date:  2011-09-21       Impact factor: 6.167

5.  Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture.

Authors:  S J Hewett; T F Uliasz; A S Vidwans; J A Hewett
Journal:  J Pharmacol Exp Ther       Date:  2000-05       Impact factor: 4.030

Review 6.  Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior.

Authors:  Michael M Halassa; Philip G Haydon
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

Review 7.  Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas.

Authors:  Nephi Stella
Journal:  Glia       Date:  2010-07       Impact factor: 7.452

8.  Brain monoglyceride lipase participating in endocannabinoid inactivation.

Authors:  T P Dinh; D Carpenter; F M Leslie; T F Freund; I Katona; S L Sensi; S Kathuria; D Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

Review 9.  Chemical probes of endocannabinoid metabolism.

Authors:  Jacqueline L Blankman; Benjamin F Cravatt
Journal:  Pharmacol Rev       Date:  2013-03-19       Impact factor: 25.468

10.  Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.

Authors:  Jonathan Z Long; Weiwei Li; Lamont Booker; James J Burston; Steven G Kinsey; Joel E Schlosburg; Franciso J Pavón; Antonia M Serrano; Dana E Selley; Loren H Parsons; Aron H Lichtman; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2008-11-23       Impact factor: 15.040

View more
  42 in total

Review 1.  Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?

Authors:  Cecilia J Hillard
Journal:  Neuropsychopharmacology       Date:  2017-06-27       Impact factor: 7.853

Review 2.  Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder.

Authors:  Mariah M Wu; Xinwen Zhang; Melissa J Asher; Stanley A Thayer
Journal:  Brain Res       Date:  2019-09-17       Impact factor: 3.252

Review 3.  Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling.

Authors:  Gernot F Grabner; Robert Zimmermann; Rudolf Schicho; Ulrike Taschler
Journal:  Pharmacol Ther       Date:  2017-02-14       Impact factor: 12.310

Review 4.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

Review 5.  Cannabinoids and glial cells: possible mechanism to understand schizophrenia.

Authors:  Valéria de Almeida; Daniel Martins-de-Souza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-02-01       Impact factor: 5.270

6.  Shotgun Lipidomics Approach to Stabilize the Regiospecificity of Monoglycerides Using a Facile Low-Temperature Derivatization Enabling Their Definitive Identification and Quantitation.

Authors:  Kui Yang; Beverly G Dilthey; Richard W Gross
Journal:  Anal Chem       Date:  2016-09-26       Impact factor: 6.986

7.  Monoacylglycerol lipase inhibitor JZL184 prevents HIV-1 gp120-induced synapse loss by altering endocannabinoid signaling.

Authors:  Xinwen Zhang; Stanley A Thayer
Journal:  Neuropharmacology       Date:  2017-10-20       Impact factor: 5.250

8.  Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination.

Authors:  Andrea Manterola; Ana Bernal-Chico; Raffaela Cipriani; Manuel Canedo-Antelo; Álvaro Moreno-García; Mar Martín-Fontecha; Fernando Pérez-Cerdá; María Victoria Sánchez-Gómez; Silvia Ortega-Gutiérrez; J Mark Brown; Ku-Lung Hsu; Benjamin Cravatt; Carlos Matute; Susana Mato
Journal:  Biochem Pharmacol       Date:  2018-08-01       Impact factor: 5.858

Review 9.  The Endocannabinoid Signaling System in the CNS: A Primer.

Authors:  Cecilia J Hillard
Journal:  Int Rev Neurobiol       Date:  2015-11-06       Impact factor: 3.230

10.  Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition.

Authors:  Daisuke Ogasawara; Hui Deng; Andreu Viader; Marc P Baggelaar; Arjen Breman; Hans den Dulk; Adrianus M C H van den Nieuwendijk; Adriann M C H van den Nieuwendijk; Marjolein Soethoudt; Tom van der Wel; Juan Zhou; Herman S Overkleeft; Manuel Sanchez-Alavez; Simone Mori; Simone Mo; William Nguyen; Bruno Conti; Xiaojie Liu; Yao Chen; Qing-Song Liu; Benjamin F Cravatt; Mario van der Stelt
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.